ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for monitor Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

CYT Cyteir Therapeutics Inc

3.02
0.00 (0.00%)
07 May 2024 - Cerrado
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
Cyteir Therapeutics Inc CYT NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
0.00 0.00% 3.02 19:00:00
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
3.02 3.02
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
07/3/202415:31EDGAR2Form 8-K - Current report
07/3/202415:30BWCyteir Announces Timeline for Voluntarily Delisting from..
05/3/202417:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202418:36EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
13/2/202418:14EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
27/12/202315:00EDGAR2Form 8-K - Current report
14/12/202315:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/12/202315:05EDGAR2Form 8-K - Current report
05/12/202315:05EDGAR2Form 8-K - Current report
22/11/202312:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202315:01EDGAR2Form 8-K - Current report
06/11/202315:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
12/10/202315:14EDGAR2Form DEFM14A - Definitive proxy statement relating to merger..
12/10/202306:52EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
12/10/202306:51EDGAR2Form 8-K - Current report
12/10/202306:30BWOngoing Results From a Dose Expansion Cohort of CYT-0851 in..
05/10/202315:00EDGAR2Form 8-K - Current report
02/10/202315:44EDGAR2Form PREM14A - Preliminary proxy statements relating to..
07/8/202315:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
30/6/202316:29EDGAR2Form 144 - Report of proposed sale of securities
30/6/202309:37EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
30/6/202309:22EDGAR2Form 8-K - Current report
30/6/202307:00BWCyteir Therapeutics Announces Discontinuation of CYT-0851..
03/6/202308:00BWPreliminary Ongoing Results with CYT-0851 in Combination..
10/5/202315:01BWCyteir Therapeutics Reports First Quarter 2023 Financial..

Su Consulta Reciente

Delayed Upgrade Clock